The significance of serum pepsinogen levels in gastric diseases
Mei Tao
Abstract
Mei Tao
Abstract
Objective To explore the relationship of serum pepsinogen and gastric lesions through detection of the serum pepsinogen I and pepsinogen II levels. Methods Observational case-control study was adopted and 834 patients were selected in this study.The patients'diagnosis was confirmed by pathological examination of biopsy before the serum tests.The patients were divided into 6 groups:106 cases with erosive gastritis,208 cases with atrophic gastritis,102 cases with gastric ulcer,108 cases with duodenal ulcer,106 cases with gastric cancer and 204 cases with normal control.Every patient's pepsinogen I and pepsinogen II were tested by ELISA. Results The serum pepsinogen I and PGR(PGⅠ/PGⅡ) level were increased significantly in erosive gastritis group(140.71±31.51μg/L,14.06±5.01),duodenal ulcer group(145.43±34. 15μg/L,15.24±4.11) and gastric ulcer group(141.63±33.26μg/L,14.71±1.91),and were decreased significantly in atrophic gastritis group(88. 53±17. 95μg/L,7. 26±2. 51) than normal control group(124.89±33.26μg/L,11.19±4.79).And its serum level in gastric cancer group(49.76±19.52μg/L,2.76±1.21) was lower significantly than normal control group and atrophic gastritis group (P0.05).Conclusions The decreased serum pepsinogen I and PGR levels were used as an effective means of screening atrophic gastritis and gastric cancer which may help to improve the diagnostic rate of early gastric cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the relationship of serum pepsinogen and gastric lesions through detection of the serum pepsinogen I and pepsinogen II levels. Methods Observational case-control study was adopted and 834 patients were selected in this study.The patients'diagnosis was confirmed by pathological examination of biopsy before the serum tests.The patients were divided into 6 groups:106 cases with erosive gastritis,208 cases with atrophic gastritis,102 cases with gastric ulcer,108 cases with duodenal ulcer,106 cases with gastric cancer and 204 cases with normal control.Every patient's pepsinogen I and pepsinogen II were tested by ELISA. Results The serum pepsinogen I and PGR(PGⅠ/PGⅡ) level were increased significantly in erosive gastritis group(140.71±31.51μg/L,14.06±5.01),duodenal ulcer group(145.43±34. 15μg/L,15.24±4.11) and gastric ulcer group(141.63±33.26μg/L,14.71±1.91),and were decreased significantly in atrophic gastritis group(88. 53±17. 95μg/L,7. 26±2. 51) than normal control group(124.89±33.26μg/L,11.19±4.79).And its serum level in gastric cancer group(49.76±19.52μg/L,2.76±1.21) was lower significantly than normal control group and atrophic gastritis group (P0.05).Conclusions The decreased serum pepsinogen I and PGR levels were used as an effective means of screening atrophic gastritis and gastric cancer which may help to improve the diagnostic rate of early gastric cancer.
Key concepts: Atrophic gastritis, Gastroenterology, Internal medicine, Medicine, Pepsin, Gastritis, Pathological, Cancer